Evidence map›Paper›PMID 32209092›Full record

ArticleBMC medicine2020

Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection.

Daniel M Muema, Ngomu A Akilimali, Okechukwu C Ndumnego, Sipho S Rasehlo, Raveshni Durgiah, Doty B A Ojwach, Nasreen Ismail, Mary Dong, Amber Moodley, Krista L Dong and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Cytokine Storm Syndrome as a Manifestation of Primary HIV Infection.Advances in experimental medicine and biology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 5 countries.

Daniel M MuemaAfrica Health Research Institute, Durban, South Africa.
Ngomu A AkilimaliAfrica Health Research Institute, Durban, South Africa.
Okechukwu C NdumnegoAfrica Health Research Institute, Durban, South Africa.
Sipho S RasehloAfrica Health Research Institute, Durban, South Africa.
Raveshni DurgiahAfrica Health Research Institute, Durban, South Africa.
Doty B A OjwachHIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Nasreen IsmailHIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Mary DongHIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Amber MoodleyHIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Krista L DongHIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Zaza M NdhlovuAfrica Health Research Institute, Durban, South Africa.
Jenniffer M MabukaAfrica Health Research Institute, Durban, South Africa.
Bruce D WalkerHIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Jaclyn K MannHIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Thumbi Ndung'uAfrica Health Research Institute, Durban, South Africa. thumbi.ndungu@ahri.org.ORCID 0000-0003-2962-3992
Africa Health Research Institute · ZAUniversity of KwaZulu-Natal · ZARagon Institute of MGH, MIT and Harvard · USKenya Medical Research Institute · KEMax Planck Institute for Infection Biology · DE

Funding

DELTAS Africa Initiative DEL-15-006International AIDS Vaccine Initiative UKZNRSA1001Wellcome Trust 107752/Z/15/Z
6 · The paper itself

Abstract

introductionImmunological damage in acute HIV infection (AHI) may predispose to detrimental clinical sequela. However, studies on the earliest HIV-induced immunological changes are limited, particularly in sub-Saharan Africa. We assessed the plasma cytokines kinetics, and their associations with virological and immunological parameters, in a well-characterized AHI cohort where participants were diagnosed before peak viremia.

methodsBlood cytokine levels were measured using Luminex and ELISA assays pre-infection, during the hyperacute infection phase (before or at peak viremia, 1-11 days after the first detection of viremia), after peak viremia (24-32 days), and during the early chronic phase (77-263 days). Gag-protease-driven replicative capacities of the transmitted/founder viruses were determined using a green fluorescent reporter T cell assay. Complete blood counts were determined before and immediately following AHI detection before ART initiation.

resultsUntreated AHI was associated with a cytokine storm of 12 out of the 33 cytokines analyzed. Initiation of ART during Fiebig stages I-II abrogated the cytokine storm. In untreated AHI, virus replicative capacity correlated positively with IP-10 (rho = 0.84, P < 0.001) and IFN-alpha (rho = 0.59, P = 0.045) and inversely with nadir CD4

conclusionWhile commencement of ART during Fiebig stages I-II of AHI abrogated the HIV-induced cytokine storm, significant depletions of eosinophils, basophils, and lymphocytes, as well as transient expansions of monocytes, were still observed in these individuals in the hyperacute phase before the initiation of ART, suggesting that even ART initiated during the onset of viremia does not abrogate all HIV-induced immune changes.

Indexed as

AdolescentAdultCytokinesFemaleHIV InfectionsHumansMaleViral LoadViremiaYoung AdultCytokinesAcute HIV infectionCytokine stormEarly ARTReplication capacity

Identifiers

PMID32209092
PMCPMC7093991
OpenAlexW3013374572

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.